A biased allosteric modulator is a molecular glue for β<sub>2</sub>AR dimerization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42618785.
- Also identified by DOI 10.1038/s41586-026-10892-y.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Family A G-protein-coupled receptors (GPCRs) are typically described as monomers, yet growing evidence suggests that they can form dimers with distinct signalling properties<sup>1-3</sup>. However, the mechanisms and therapeutic potential of such dimerization remain poorly understood. Here we show that AP-7-168, an optimized derivative of a β-arrestin-biased negative allosteric modulator of the β<sub>2</sub>-adrenergic receptor (β<sub>2</sub>AR) that sustains bronchorelaxation in cell and tissue models<sup>4</sup>, functions as a molecular glue to stabilize β<sub>2</sub>AR homodimerization. Cryogenic electron microscopy structures reveal a unique binding mode in which two AP-7-168 molecules pack within a pocket formed by transmembrane helices 3, 4 and 5 of two protomers, stabilizing a dimeric conformation that selectively prevents β-arrestin coupling. In cells, AP-7-168 robustly stabilizes β<sub>2</sub>AR dimerization and drives enlarged nanocluster formation. Combined with extensive functional studies, our findings identify an allosteric mechanism by which a small molecule biases β<sub>2</sub>AR signalling through dimerization, highlighting ligand-stabilized dimerization as a strategy for GPCR modulation.